Menu
Recruiting NCT07094061

Neurobehavioral Signatures of Sign- and Goal-Tracking in Emerging Adults: Translation of a Preclinical Model

No phase Interventional Substance Use Healthy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: fMRI, Questionnaires and surveys, Behavioral tasks and eye tracking.
Who it may be relevant to
Registry conditions: Substance Use, Healthy. Basic parameters: 18 years — 22 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study seeks to understand individual differences in personality, brain function, and behavior. Study hypothesis: \- A stronger sign-tracking bias will be associated with a bottom-up processing style characterized by less adaptive attentional- and impulse-control as well as hyperactive reward processing, whereas a stronger goal-tracking bias will be associated with a top-down processing style characterized by strong attentional- and impulse-control as well as normative reward processing.

Interventions

  • Device fMRI
    Participants will have an MRI to scan participants brains and will wear skin conductance electrodes on the hand and fill out questionnaires. Scanning will take approximately 90 minutes. While lying in the scanner, participants will be asked to perform some tasks. The tasks will be presented to participants visually on a screen in the scanner and eye movements will also be tracked during some of these tasks. Participants will respond to stimuli with button presses that are recorded by computer.
  • Behavioral Questionnaires and surveys
    Participants will have multiple visits during this study and fill out various surveys at these visits.
  • Behavioral Behavioral tasks and eye tracking
    Participants will perform behavioral tasks while having eye-tracking hardware monitor participants eye movements. A video camera will be used to record eye movements during the behavioral tasks.

Primary outcome measures

  • Correlation between Pavlovian conditioned approach (PavCA) bias score (out-of-scanner) and composite cannabis use score [Time frame: Baseline]
Secondary outcome measures (1)
  • Correlation between PavCA bias score (out-of-scanner) and activation from the Cannabis Cue Reactivity Task (P-CAN) [Time frame: Baseline]

Eligibility criteria

Inclusion criteria

  • 18-22 years old at baseline
  • Right-handed
  • Medically/physically able to give informed consent
  • English-speaking
  • Substance use is free to vary, but for participants with a history of substance use, ≥ 1 use of cannabis (including less than a full dose)

Exclusion criteria

  • Acute or chronic medical or neurological illness (e.g., diabetes, epilepsy, migraine)
  • History of psychosis in self or first-degree relative
  • Current treatment for substance use disorder
  • Current or past 6-month treatment with centrally acting medications (not including attention deficit hyperactivity disorder (ADHD) medication)
  • Intelligence quotient (IQ) < 70
  • Lifetime history of head trauma with loss of consciousness > 5 minutes
  • Reliance on glasses to be able to read small text at a distance of approximately 30 inches
  • Colorblindness
  • MRI contraindication (e.g., pregnancy, metal implants, claustrophobia) per protocol

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Basic science

Study locations

United States · 2 centers
  • Rachel Upjohn Building — Ann Arbor
  • University of Michigan — Ann Arbor

Identifiers

NCT: NCT07094061 · HUM00269332 · R01DA058010

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗